{"product_id":"sermorelin-10mg-vial","title":"Sermorelin 10mg vial","description":"\u003ch3\u003e\n\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cstrong\u003e                                      \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/strong\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eFOR HUMAN \u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003e\u003cstrong\u003eCONSUMPTION\u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\n\u003c\/h3\u003e\n\u003cp data-end=\"625\" data-start=\"44\"\u003eSermorelin is a synthetic \u003cstrong data-end=\"166\" data-start=\"111\"\u003egrowth-hormone–releasing hormone (GHRH 1–29) analog\u003c\/strong\u003e that binds pituitary \u003cstrong data-end=\"214\" data-start=\"188\"\u003eGHRH receptors (GHRHR)\u003c\/strong\u003e to provoke \u003cstrong data-end=\"263\" data-start=\"226\"\u003ephysiologic, pulsatile GH release\u003c\/strong\u003e and downstream increases in \u003cstrong data-end=\"301\" data-start=\"292\"\u003eIGF-1\u003c\/strong\u003e. In the U.S., sermorelin was previously marketed as \u003cstrong data-end=\"382\" data-start=\"354\"\u003eGeref®\/Geref Diagnostic®\u003c\/strong\u003e for evaluating pituitary GH reserve; it is \u003cstrong data-end=\"499\" data-start=\"426\"\u003enot FDA-approved for chronic treatment of growth disorders or obesity\u003c\/strong\u003e and branded drug was discontinued for non-safety\/commercial reasons. Compounded products are used off-label in some settings.\u003c\/p\u003e\n\u003chr data-end=\"630\" data-start=\"627\"\u003e\n\u003ch3 data-end=\"693\" data-start=\"632\"\u003eAdditional Benefits of Sermorelin Now Under Investigation\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"3157\" data-start=\"695\"\u003e\n\u003cthead data-end=\"723\" data-start=\"695\"\u003e\n\u003ctr data-end=\"723\" data-start=\"695\"\u003e\n\u003cth data-col-size=\"md\" data-end=\"705\" data-start=\"695\"\u003eBenefit\u003c\/th\u003e\n\u003cth data-col-size=\"xl\" data-end=\"723\" data-start=\"705\"\u003eKey take-aways\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"3157\" data-start=\"734\"\u003e\n\u003ctr data-end=\"1054\" data-start=\"734\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"785\" data-start=\"734\"\u003e\u003cstrong data-end=\"784\" data-start=\"736\"\u003e1 Physiologic GH restoration vs exogenous GH\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"1054\" data-start=\"785\" data-col-size=\"xl\"\u003eSermorelin elicits \u003cstrong data-end=\"834\" data-start=\"806\"\u003eendogenous, pulsatile GH\u003c\/strong\u003e with intact hypothalamic feedback (somatostatin\/IGF-1), typically raising IGF-1 \u003cstrong data-end=\"971\" data-start=\"915\"\u003einto—rather than above—the age-adjusted normal range\u003c\/strong\u003e. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Endocrine Reviews; Journal of Clinical Endocrinology \u0026amp; Metabolism\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1335\" data-start=\"1055\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1094\" data-start=\"1055\"\u003e\u003cstrong data-end=\"1093\" data-start=\"1057\"\u003e2 Diagnostic utility for GH axis\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"1335\" data-start=\"1094\" data-col-size=\"xl\"\u003eAs a \u003cstrong data-end=\"1126\" data-start=\"1101\"\u003eGHRH stimulation test\u003c\/strong\u003e (often 1 µg\/kg IV), sermorelin helps differentiate \u003cstrong data-end=\"1207\" data-start=\"1178\"\u003ehypothalamic vs pituitary\u003c\/strong\u003e deficits and can increase diagnostic sensitivity when combined with \u003cstrong data-end=\"1301\" data-start=\"1276\"\u003earginine or clonidine\u003c\/strong\u003e. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;JCEM; Pediatrics\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1563\" data-start=\"1336\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1377\" data-start=\"1336\"\u003e\u003cstrong data-end=\"1376\" data-start=\"1338\"\u003e3 Sleep architecture \u0026amp; SWS support\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"1563\" data-start=\"1377\" data-col-size=\"xl\"\u003eGHRH analogs including sermorelin \u003cstrong data-end=\"1440\" data-start=\"1413\"\u003eaugment slow-wave sleep\u003c\/strong\u003e and \u003cstrong data-end=\"1473\" data-start=\"1445\"\u003enighttime GH pulsatility\u003c\/strong\u003e, especially in midlife adults with blunted SWS. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Sleep; Neuroendocrinology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1858\" data-start=\"1564\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1597\" data-start=\"1564\"\u003e\u003cstrong data-end=\"1596\" data-start=\"1566\"\u003e4 Body-composition signals\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"1858\" data-start=\"1597\" data-col-size=\"xl\"\u003eSmall open-label series report \u003cstrong data-end=\"1654\" data-start=\"1630\"\u003emodest VAT reduction\u003c\/strong\u003e and \u003cstrong data-end=\"1689\" data-start=\"1659\"\u003efat-free mass preservation\u003c\/strong\u003e under nightly SC dosing, consistent with GH physiology; effects are \u003cstrong data-end=\"1797\" data-start=\"1758\"\u003esmaller than with tesamorelin or GH\u003c\/strong\u003e. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Metabolism; Hormone Research in Paediatrics\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2062\" data-start=\"1859\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1881\" data-start=\"1859\"\u003e\u003cstrong data-end=\"1880\" data-start=\"1861\"\u003e5 Bone turnover\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2062\" data-start=\"1881\" data-col-size=\"xl\"\u003eShort-term increases in \u003cstrong data-end=\"1953\" data-start=\"1907\"\u003ebone-formation markers (P1NP, osteocalcin)\u003c\/strong\u003e via GH→IGF-1 pathways; long-term fracture data are lacking. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Bone; Osteoporosis International\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2327\" data-start=\"2063\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2110\" data-start=\"2063\"\u003e\u003cstrong data-end=\"2109\" data-start=\"2065\"\u003e6 Exercise recovery \u0026amp; collagen synthesis\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2327\" data-start=\"2110\" data-col-size=\"xl\"\u003eBy restoring \u003cstrong data-end=\"2148\" data-start=\"2125\"\u003enocturnal GH pulses\u003c\/strong\u003e, sermorelin may support \u003cstrong data-end=\"2211\" data-start=\"2173\"\u003etendon\/ligament collagen synthesis\u003c\/strong\u003eand recovery, though high-quality RCTs are limited. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;American Journal of Physiology; Sports Medicine\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2602\" data-start=\"2328\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2364\" data-start=\"2328\"\u003e\u003cstrong data-end=\"2363\" data-start=\"2330\"\u003e7 Cognitive\/affective domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2602\" data-start=\"2364\" data-col-size=\"xl\"\u003eIn older adults, \u003cstrong data-end=\"2407\" data-start=\"2383\"\u003eGHRH analog regimens\u003c\/strong\u003e improved \u003cstrong data-end=\"2450\" data-start=\"2417\"\u003eexecutive function and memory\u003c\/strong\u003e in small trials; sermorelin is mechanistically similar but \u003cstrong data-end=\"2547\" data-start=\"2510\"\u003edirect sermorelin RCTs are sparse\u003c\/strong\u003e. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Archives of Neurology; JAMA Neurology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2880\" data-start=\"2603\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2635\" data-start=\"2603\"\u003e\u003cstrong data-end=\"2634\" data-start=\"2605\"\u003e8 Cardiometabolic markers\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2880\" data-start=\"2635\" data-col-size=\"xl\"\u003eResponders may show \u003cstrong data-end=\"2680\" data-start=\"2657\"\u003elower triglycerides\u003c\/strong\u003e and \u003cstrong data-end=\"2707\" data-start=\"2685\"\u003ehigher adiponectin\u003c\/strong\u003e in parallel with IGF-1 normalization; glucose impact is \u003cstrong data-end=\"2793\" data-start=\"2764\"\u003eneutral to mildly adverse\u003c\/strong\u003e and requires monitoring. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Diabetes Care; Journal of Clinical Lipidology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3157\" data-start=\"2881\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2920\" data-start=\"2881\"\u003e\u003cstrong data-end=\"2919\" data-start=\"2883\"\u003e9 Pediatric transition scenarios\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"3157\" data-start=\"2920\" data-col-size=\"xl\"\u003eAs a physiologic secretagogue, sermorelin has been explored for \u003cstrong data-end=\"3015\" data-start=\"2986\"\u003eborderline\/functional GHD\u003c\/strong\u003e and \u003cstrong data-end=\"3049\" data-start=\"3020\"\u003etransition-age assessment\u003c\/strong\u003e, but \u003cstrong data-end=\"3094\" data-start=\"3055\"\u003esomatropin remains standard therapy\u003c\/strong\u003e. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Pediatrics; European Journal of Endocrinology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"3162\" data-start=\"3159\"\u003e\n\u003ch2 data-end=\"3199\" data-start=\"3164\"\u003e2. Molecular Mechanism of Action\u003c\/h2\u003e\n\u003ch3 data-end=\"3236\" data-start=\"3201\"\u003e2.1 Receptor Pharmacodynamics\u003c\/h3\u003e\n\u003cp data-end=\"3556\" data-start=\"3237\"\u003eSermorelin binds \u003cstrong data-end=\"3263\" data-start=\"3254\"\u003eGHRHR\u003c\/strong\u003e on pituitary somatotrophs → \u003cstrong data-end=\"3330\" data-start=\"3292\"\u003eGs–adenylate cyclase–cAMP–PKA–CREB\u003c\/strong\u003e activation → \u003cstrong data-end=\"3356\" data-start=\"3344\"\u003eGH pulse\u003c\/strong\u003e generation. Peripheral \u003cstrong data-end=\"3386\" data-start=\"3380\"\u003eGH\u003c\/strong\u003e acts via \u003cstrong data-end=\"3414\" data-start=\"3396\"\u003eGHR–JAK2–STAT5\u003c\/strong\u003e, increasing hepatic \u003cstrong data-end=\"3444\" data-start=\"3435\"\u003eIGF-1\u003c\/strong\u003e and lipolytic enzymes; \u003cstrong data-end=\"3484\" data-start=\"3468\"\u003esomatostatin\u003c\/strong\u003e and \u003cstrong data-end=\"3498\" data-start=\"3489\"\u003eIGF-1\u003c\/strong\u003e furnish negative feedback, preserving physiologic rhythm.\u003c\/p\u003e\n\u003ch3 data-end=\"3585\" data-start=\"3558\"\u003e2.2 Down-stream Biology\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"3901\" data-start=\"3587\"\u003e\n\u003cthead data-end=\"3629\" data-start=\"3587\"\u003e\n\u003ctr data-end=\"3629\" data-start=\"3587\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3597\" data-start=\"3587\"\u003ePathway\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"3618\" data-start=\"3597\"\u003eFunctional outcome\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3629\" data-start=\"3618\"\u003eContext\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"3901\" data-start=\"3644\"\u003e\n\u003ctr data-end=\"3726\" data-start=\"3644\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3662\" data-start=\"3644\"\u003eJAK2–STAT5 (GH)\u003c\/td\u003e\n\u003ctd data-end=\"3708\" data-start=\"3662\" data-col-size=\"md\"\u003e↑ IGF-1, ↑ lipolysis, ↓ de novo lipogenesis\u003c\/td\u003e\n\u003ctd data-end=\"3726\" data-start=\"3708\" data-col-size=\"sm\"\u003eLiver, adipose\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3809\" data-start=\"3727\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3751\" data-start=\"3727\"\u003ePI3K–Akt–mTOR (IGF-1)\u003c\/td\u003e\n\u003ctd data-end=\"3790\" data-start=\"3751\" data-col-size=\"md\"\u003e↑ protein synthesis, ↑ fat-free mass\u003c\/td\u003e\n\u003ctd data-end=\"3809\" data-start=\"3790\" data-col-size=\"sm\"\u003eSkeletal muscle\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3901\" data-start=\"3810\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3837\" data-start=\"3810\"\u003eCNS sleep network (GHRH)\u003c\/td\u003e\n\u003ctd data-end=\"3878\" data-start=\"3837\" data-col-size=\"md\"\u003e↑ slow-wave sleep, nocturnal GH pulses\u003c\/td\u003e\n\u003ctd data-end=\"3901\" data-start=\"3878\" data-col-size=\"sm\"\u003eHypothalamus\/cortex\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"3906\" data-start=\"3903\"\u003e\n\u003ch2 data-end=\"3930\" data-start=\"3908\"\u003e3. Pharmacokinetics\u003c\/h2\u003e\n\u003cul data-end=\"4267\" data-start=\"3932\"\u003e\n\u003cli data-end=\"3996\" data-start=\"3932\"\u003e\n\u003cp data-end=\"3996\" data-start=\"3934\"\u003e\u003cstrong data-end=\"3949\" data-start=\"3934\"\u003eAbsorption:\u003c\/strong\u003e Rapid after SC; diagnostic use often \u003cstrong data-end=\"3993\" data-start=\"3987\"\u003eIV\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4104\" data-start=\"3997\"\u003e\n\u003cp data-end=\"4104\" data-start=\"3999\"\u003e\u003cstrong data-end=\"4013\" data-start=\"3999\"\u003eHalf-life:\u003c\/strong\u003e \u003cstrong data-end=\"4028\" data-start=\"4014\"\u003e~10–20 min\u003c\/strong\u003e (short), necessitating \u003cstrong data-end=\"4080\" data-start=\"4052\"\u003ebedtime or repeat dosing\u003c\/strong\u003e for therapeutic aims.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4195\" data-start=\"4105\"\u003e\n\u003cp data-end=\"4195\" data-start=\"4107\"\u003e\u003cstrong data-end=\"4124\" data-start=\"4107\"\u003eDistribution:\u003c\/strong\u003e Acts primarily at pituitary; systemic effects mediated via GH\/IGF-1.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4267\" data-start=\"4196\"\u003e\n\u003cp data-end=\"4267\" data-start=\"4198\"\u003e\u003cstrong data-end=\"4212\" data-start=\"4198\"\u003eClearance:\u003c\/strong\u003e Proteolytic degradation; no CYP interactions expected.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"4272\" data-start=\"4269\"\u003e\n\u003ch2 data-end=\"4319\" data-start=\"4274\"\u003e4. Pre-clinical and Translational Evidence\u003c\/h2\u003e\n\u003ch3 data-end=\"4356\" data-start=\"4321\"\u003e4.1 Adult \u0026amp; Pediatric GH Axis\u003c\/h3\u003e\n\u003cp data-end=\"4594\" data-start=\"4357\"\u003eSermorelin reliably increases \u003cstrong data-end=\"4399\" data-start=\"4387\"\u003eGH\/IGF-1\u003c\/strong\u003e in subjects with intact somatotrophs; blunted\/absent responses suggest \u003cstrong data-end=\"4492\" data-start=\"4471\"\u003epituitary disease\u003c\/strong\u003e. Pediatric evaluation shows good tolerability and diagnostic yield in conjunction with other stimuli.\u003c\/p\u003e\n\u003ch3 data-end=\"4628\" data-start=\"4596\"\u003e4.2 Sleep \u0026amp; Neurocognition\u003c\/h3\u003e\n\u003cp data-end=\"4798\" data-start=\"4629\"\u003eGHRH-based paradigms improve \u003cstrong data-end=\"4677\" data-start=\"4658\"\u003eslow-wave sleep\u003c\/strong\u003e and may enhance \u003cstrong data-end=\"4716\" data-start=\"4694\"\u003eexecutive function\u003c\/strong\u003e in aging cohorts; direct sermorelin data are limited but mechanistically aligned.\u003c\/p\u003e\n\u003ch3 data-end=\"4839\" data-start=\"4800\"\u003e4.3 Body Composition \/ Metabolism\u003c\/h3\u003e\n\u003cp data-end=\"5027\" data-start=\"4840\"\u003eExploratory studies indicate \u003cstrong data-end=\"4894\" data-start=\"4869\"\u003emodest VAT reductions\u003c\/strong\u003e and \u003cstrong data-end=\"4921\" data-start=\"4899\"\u003elipid improvements\u003c\/strong\u003e with nightly SC administration; effects regress after \u003cstrong data-end=\"4995\" data-start=\"4976\"\u003ediscontinuation\u003c\/strong\u003e, consistent with GH physiology.\u003c\/p\u003e\n\u003chr data-end=\"5032\" data-start=\"5029\"\u003e\n\u003ch2 data-end=\"5067\" data-start=\"5034\"\u003e5. Emerging Clinical Interests\u003c\/h2\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"5620\" data-start=\"5069\"\u003e\n\u003cthead data-end=\"5107\" data-start=\"5069\"\u003e\n\u003ctr data-end=\"5107\" data-start=\"5069\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"5077\" data-start=\"5069\"\u003eField\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"5089\" data-start=\"5077\"\u003eRationale\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"5107\" data-start=\"5089\"\u003eCurrent status\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"5620\" data-start=\"5122\"\u003e\n\u003ctr data-end=\"5274\" data-start=\"5122\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5153\" data-start=\"5122\"\u003e\u003cstrong data-end=\"5152\" data-start=\"5124\"\u003eDiagnostic endocrinology\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"5206\" data-start=\"5153\" data-col-size=\"md\"\u003eDifferentiate hypothalamic vs pituitary GH defects\u003c\/td\u003e\n\u003ctd data-end=\"5274\" data-start=\"5206\" data-col-size=\"md\"\u003eEstablished methodology, less common since widespread IGF-1\/ITTs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5404\" data-start=\"5275\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5306\" data-start=\"5275\"\u003e\u003cstrong data-end=\"5305\" data-start=\"5277\"\u003eSarcopenic obesity\/aging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"5357\" data-start=\"5306\" data-col-size=\"md\"\u003ePhysiologic GH restoration with feedback control\u003c\/td\u003e\n\u003ctd data-end=\"5404\" data-start=\"5357\" data-col-size=\"md\"\u003ePilot\/open-label studies; no pivotal trials\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5509\" data-start=\"5405\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5432\" data-start=\"5405\"\u003e\u003cstrong data-end=\"5431\" data-start=\"5407\"\u003eNeurocognitive aging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"5470\" data-start=\"5432\" data-col-size=\"md\"\u003eGHRH→GH→IGF-1 neurotrophic pathways\u003c\/td\u003e\n\u003ctd data-end=\"5509\" data-start=\"5470\" data-col-size=\"md\"\u003eSmall RCT signals with GHRH analogs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5620\" data-start=\"5510\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5531\" data-start=\"5510\"\u003e\u003cstrong data-end=\"5530\" data-start=\"5512\"\u003eSleep medicine\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"5575\" data-start=\"5531\" data-col-size=\"md\"\u003eAugment SWS in midlife adults with low GH\u003c\/td\u003e\n\u003ctd data-end=\"5620\" data-start=\"5575\" data-col-size=\"md\"\u003eProof-of-concept data; more trials needed\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"5625\" data-start=\"5622\"\u003e\n\u003ch2 data-end=\"5656\" data-start=\"5627\"\u003e6. Safety and Tolerability\u003c\/h2\u003e\n\u003cul data-end=\"6241\" data-start=\"5658\"\u003e\n\u003cli data-end=\"5770\" data-start=\"5658\"\u003e\n\u003cp data-end=\"5770\" data-start=\"5660\"\u003e\u003cstrong data-end=\"5671\" data-start=\"5660\"\u003eCommon:\u003c\/strong\u003e Transient \u003cstrong data-end=\"5694\" data-start=\"5682\"\u003eflushing\u003c\/strong\u003e, \u003cstrong data-end=\"5706\" data-start=\"5696\"\u003ewarmth\u003c\/strong\u003e, \u003cstrong data-end=\"5718\" data-start=\"5708\"\u003enausea\u003c\/strong\u003e, \u003cstrong data-end=\"5732\" data-start=\"5720\"\u003eheadache\u003c\/strong\u003e, mild \u003cstrong data-end=\"5767\" data-start=\"5739\"\u003einjection-site reactions\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5899\" data-start=\"5771\"\u003e\n\u003cp data-end=\"5899\" data-start=\"5773\"\u003e\u003cstrong data-end=\"5787\" data-start=\"5773\"\u003eEndocrine:\u003c\/strong\u003e \u003cstrong data-end=\"5802\" data-start=\"5788\"\u003eIGF-1 rise\u003c\/strong\u003e—monitor to keep within age-normal range; \u003cstrong data-end=\"5855\" data-start=\"5844\"\u003eglucose\u003c\/strong\u003e can drift upward in susceptible patients.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6083\" data-start=\"5900\"\u003e\n\u003cp data-end=\"6083\" data-start=\"5902\"\u003e\u003cstrong data-end=\"5933\" data-start=\"5902\"\u003eContraindications\/Cautions:\u003c\/strong\u003e \u003cstrong data-end=\"5955\" data-start=\"5934\"\u003eActive malignancy\u003c\/strong\u003e, pregnancy, hypersensitivity. Use caution in \u003cstrong data-end=\"6015\" data-start=\"6001\"\u003esevere OSA\u003c\/strong\u003e, \u003cstrong data-end=\"6041\" data-start=\"6017\"\u003ediabetic retinopathy\u003c\/strong\u003e, or \u003cstrong data-end=\"6075\" data-start=\"6046\"\u003eintracranial hypertension\u003c\/strong\u003e risk.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6241\" data-start=\"6084\"\u003e\n\u003cp data-end=\"6241\" data-start=\"6086\"\u003e\u003cstrong data-end=\"6106\" data-start=\"6086\"\u003eAbuse potential:\u003c\/strong\u003e Off-label\/compounded use exists; safety beyond short-term diagnostic dosing is \u003cstrong data-end=\"6213\" data-start=\"6186\"\u003eless well characterized\u003c\/strong\u003e than for tesamorelin or GH.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"6272\" data-start=\"6243\"\u003e\u003cstrong data-end=\"6272\" data-start=\"6243\"\u003eComparative safety matrix\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"6791\" data-start=\"6274\"\u003e\n\u003cthead data-end=\"6367\" data-start=\"6274\"\u003e\n\u003ctr data-end=\"6367\" data-start=\"6274\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"6284\" data-start=\"6274\"\u003eConcern\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"6309\" data-start=\"6284\"\u003eSermorelin (GHRH 1–29)\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"6348\" data-start=\"6309\"\u003eTesamorelin (stabilized GHRH analog)\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"6367\" data-start=\"6348\"\u003eSomatropin (GH)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"6791\" data-start=\"6386\"\u003e\n\u003ctr data-end=\"6479\" data-start=\"6386\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6400\" data-start=\"6386\"\u003eGH dynamics\u003c\/td\u003e\n\u003ctd data-end=\"6425\" data-start=\"6400\" data-col-size=\"sm\"\u003e\u003cstrong data-end=\"6424\" data-start=\"6402\"\u003ePhysiologic pulses\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"6451\" data-start=\"6425\" data-col-size=\"sm\"\u003ePhysiologic-like pulses\u003c\/td\u003e\n\u003ctd data-end=\"6479\" data-start=\"6451\" data-col-size=\"sm\"\u003eNon-physiologic exposure\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6562\" data-start=\"6480\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6496\" data-start=\"6480\"\u003eIGF-1 control\u003c\/td\u003e\n\u003ctd data-end=\"6519\" data-start=\"6496\" data-col-size=\"sm\"\u003e\u003cstrong data-end=\"6518\" data-start=\"6498\"\u003eFeedback-limited\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"6538\" data-start=\"6519\" data-col-size=\"sm\"\u003eFeedback-limited\u003c\/td\u003e\n\u003ctd data-end=\"6562\" data-start=\"6538\" data-col-size=\"sm\"\u003eDirectly dose-driven\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6627\" data-start=\"6563\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6582\" data-start=\"6563\"\u003eEdema\/arthralgia\u003c\/td\u003e\n\u003ctd data-end=\"6597\" data-start=\"6582\" data-col-size=\"sm\"\u003eLow–moderate\u003c\/td\u003e\n\u003ctd data-end=\"6608\" data-start=\"6597\" data-col-size=\"sm\"\u003eModerate\u003c\/td\u003e\n\u003ctd data-end=\"6627\" data-start=\"6608\" data-col-size=\"sm\"\u003eModerate–higher\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6703\" data-start=\"6628\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6645\" data-start=\"6628\"\u003eGlucose impact\u003c\/td\u003e\n\u003ctd data-end=\"6664\" data-start=\"6645\" data-col-size=\"sm\"\u003eNeutral → mild ↑\u003c\/td\u003e\n\u003ctd data-end=\"6683\" data-start=\"6664\" data-col-size=\"sm\"\u003eNeutral → mild ↑\u003c\/td\u003e\n\u003ctd data-end=\"6703\" data-start=\"6683\" data-col-size=\"sm\"\u003eNeutral → mild ↑\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6791\" data-start=\"6704\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6728\" data-start=\"6704\"\u003eEvidence base for VAT\u003c\/td\u003e\n\u003ctd data-end=\"6750\" data-start=\"6728\" data-col-size=\"sm\"\u003eLimited\/exploratory\u003c\/td\u003e\n\u003ctd data-end=\"6764\" data-start=\"6750\" data-col-size=\"sm\"\u003eRobust RCTs\u003c\/td\u003e\n\u003ctd data-end=\"6791\" data-start=\"6764\" data-col-size=\"sm\"\u003eMixed in non-GHD adults\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"6796\" data-start=\"6793\"\u003e\n\u003ch2 data-end=\"6824\" data-start=\"6798\"\u003e7. Regulatory Landscape\u003c\/h2\u003e\n\u003cul data-end=\"7277\" data-start=\"6826\"\u003e\n\u003cli data-end=\"6978\" data-start=\"6826\"\u003e\n\u003cp data-end=\"6978\" data-start=\"6828\"\u003e\u003cstrong data-end=\"6844\" data-start=\"6828\"\u003eU.S. status:\u003c\/strong\u003e Prior approval \u003cstrong data-end=\"6889\" data-start=\"6860\"\u003efor diagnostic evaluation\u003c\/strong\u003e of pituitary GH reserve (Geref\/Geref Diagnostic); \u003cstrong data-end=\"6975\" data-start=\"6940\"\u003ecommercial product discontinued\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7068\" data-start=\"6979\"\u003e\n\u003cp data-end=\"7068\" data-start=\"6981\"\u003e\u003cstrong data-end=\"7005\" data-start=\"6981\"\u003eTreatment approvals:\u003c\/strong\u003e \u003cstrong data-end=\"7014\" data-start=\"7006\"\u003eNone\u003c\/strong\u003e for chronic therapy of GHD, obesity, or anti-aging.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7277\" data-start=\"7069\"\u003e\n\u003cp data-end=\"7277\" data-start=\"7071\"\u003e\u003cstrong data-end=\"7084\" data-start=\"7071\"\u003eGuidance:\u003c\/strong\u003e Professional societies recommend \u003cstrong data-end=\"7132\" data-start=\"7118\"\u003esomatropin\u003c\/strong\u003e for confirmed GHD; \u003cstrong data-end=\"7167\" data-start=\"7152\"\u003etesamorelin\u003c\/strong\u003e for \u003cstrong data-end=\"7204\" data-start=\"7172\"\u003eHIV-associated lipodystrophy\u003c\/strong\u003e. Compounded sermorelin products lack FDA evaluation for safety\/efficacy.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"7282\" data-start=\"7279\"\u003e\n\u003ch2 data-end=\"7307\" data-start=\"7284\"\u003e8. Future Directions\u003c\/h2\u003e\n\u003cul data-end=\"7757\" data-start=\"7309\"\u003e\n\u003cli data-end=\"7423\" data-start=\"7309\"\u003e\n\u003cp data-end=\"7423\" data-start=\"7311\"\u003e\u003cstrong data-end=\"7339\" data-start=\"7311\"\u003eLong-acting GHRH analogs\u003c\/strong\u003e or \u003cstrong data-end=\"7363\" data-start=\"7343\"\u003edelivery systems\u003c\/strong\u003e (e.g., depot\/intranasal) to overcome the short half-life.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7528\" data-start=\"7424\"\u003e\n\u003cp data-end=\"7528\" data-start=\"7426\"\u003e\u003cstrong data-end=\"7449\" data-start=\"7426\"\u003eHead-to-head trials\u003c\/strong\u003e versus GH or tesamorelin in \u003cstrong data-end=\"7500\" data-start=\"7478\"\u003esarcopenic obesity\u003c\/strong\u003e and \u003cstrong data-end=\"7514\" data-start=\"7505\"\u003eNAFLD\u003c\/strong\u003e phenotypes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7665\" data-start=\"7529\"\u003e\n\u003cp data-end=\"7665\" data-start=\"7531\"\u003e\u003cstrong data-end=\"7558\" data-start=\"7531\"\u003eBiomarker-guided dosing\u003c\/strong\u003e using \u003cstrong data-end=\"7578\" data-start=\"7565\"\u003eIGF-1 SDS\u003c\/strong\u003e and \u003cstrong data-end=\"7606\" data-start=\"7583\"\u003esleep metrics (SWS)\u003c\/strong\u003e to personalize benefit while minimizing glycaemic drift.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7757\" data-start=\"7666\"\u003e\n\u003cp data-end=\"7757\" data-start=\"7668\"\u003e\u003cstrong data-end=\"7694\" data-start=\"7668\"\u003eNeurocognitive studies\u003c\/strong\u003e in aging\/MCI cohorts to test class effects on memory networks.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"7762\" data-start=\"7759\"\u003e\n\u003ch3 data-end=\"7787\" data-start=\"7764\"\u003eSelected References\u003c\/h3\u003e\n\u003cul data-end=\"8809\" data-start=\"7789\"\u003e\n\u003cli data-end=\"7903\" data-start=\"7789\"\u003e\n\u003cp data-end=\"7903\" data-start=\"7791\"\u003eThorner MO, Merriam GR, et al. \u003cstrong data-end=\"7880\" data-start=\"7822\"\u003ePhysiology and pharmacology of GHRH and secretagogues.\u003c\/strong\u003e \u003cem data-end=\"7900\" data-start=\"7881\"\u003eEndocrine Reviews\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8028\" data-start=\"7904\"\u003e\n\u003cp data-end=\"8028\" data-start=\"7906\"\u003eGeref®\/\u003cstrong data-end=\"7934\" data-start=\"7913\"\u003eGeref Diagnostic®\u003c\/strong\u003e U.S. Prescribing Information (archival): \u003cstrong data-end=\"8025\" data-start=\"7976\"\u003eSermorelin acetate for GH stimulation testing\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8140\" data-start=\"8029\"\u003e\n\u003cp data-end=\"8140\" data-start=\"8031\"\u003eHo KY, et al. \u003cstrong data-end=\"8130\" data-start=\"8045\"\u003eGH pulse generation by GHRH in adults; feedback regulation by somatostatin\/IGF-1.\u003c\/strong\u003e \u003cem data-end=\"8137\" data-start=\"8131\"\u003eJCEM\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8255\" data-start=\"8141\"\u003e\n\u003cp data-end=\"8255\" data-start=\"8143\"\u003eVan Cauter E, Born J. \u003cstrong data-end=\"8222\" data-start=\"8165\"\u003eGHRH, slow-wave sleep, and GH secretion across aging.\u003c\/strong\u003e \u003cem data-end=\"8230\" data-start=\"8223\"\u003eSleep\u003c\/em\u003e; \u003cem data-end=\"8252\" data-start=\"8232\"\u003eNeuroendocrinology\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8374\" data-start=\"8256\"\u003e\n\u003cp data-end=\"8374\" data-start=\"8258\"\u003eBaker LD, et al. \u003cstrong data-end=\"8342\" data-start=\"8275\"\u003eGHRH analog improves cognition in healthy older adults and MCI.\u003c\/strong\u003e \u003cem data-end=\"8356\" data-start=\"8343\"\u003eArch Neurol\u003c\/em\u003e; \u003cem data-end=\"8371\" data-start=\"8358\"\u003eJAMA Neurol\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8472\" data-start=\"8375\"\u003e\n\u003cp data-end=\"8472\" data-start=\"8377\"\u003eRudman D, et al. \u003cstrong data-end=\"8456\" data-start=\"8394\"\u003eBody-composition responses to GH-axis modulation in aging.\u003c\/strong\u003e \u003cem data-end=\"8469\" data-start=\"8457\"\u003eMetabolism\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8582\" data-start=\"8473\"\u003e\n\u003cp data-end=\"8582\" data-start=\"8475\"\u003eGiustina A, et al. \u003cstrong data-end=\"8543\" data-start=\"8494\"\u003eGuidelines for adult GHD diagnosis\/treatment.\u003c\/strong\u003e \u003cem data-end=\"8579\" data-start=\"8544\"\u003eEuropean Journal of Endocrinology\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8716\" data-start=\"8583\"\u003e\n\u003cp data-end=\"8716\" data-start=\"8585\"\u003eEngelson ES, Stanley TL, et al. \u003cstrong data-end=\"8672\" data-start=\"8617\"\u003eVAT, lipids, adipokines under GH-axis manipulation.\u003c\/strong\u003e \u003cem data-end=\"8679\" data-start=\"8673\"\u003eJCEM\u003c\/em\u003e; \u003cem data-end=\"8713\" data-start=\"8681\"\u003eJournal of Clinical Lipidology\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8809\" data-start=\"8717\"\u003e\n\u003cp data-end=\"8809\" data-start=\"8719\"\u003ePediatric Endocrine Society statements on \u003cstrong data-end=\"8784\" data-start=\"8761\"\u003estimulation testing\u003c\/strong\u003e and \u003cstrong data-end=\"8808\" data-start=\"8789\"\u003etransition care\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"RCpeptides","offers":[{"title":"Default Title","offer_id":52684855509330,"sku":null,"price":60.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/Sermorelin_10mg.png?v=1770834876","url":"https:\/\/sciencepeptideslab.com\/products\/sermorelin-10mg-vial","provider":"Science Peptides Lab","version":"1.0","type":"link"}